Incannex Healthcare (IXHL) Operating Leases (2022 - 2026)
Incannex Healthcare (IXHL) posted quarterly Operating Leases of $42000.0 for Q1 2026, down 85.57% year-on-year from $291000.0 in Q1 2025, and down 20.75% on a QoQ basis from $53000.0 in Q4 2025.
Incannex Healthcare (IXHL) Operating Leases (2022 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Operating Leases for 5 consecutive years, with $42000.0 the latest figure, recorded in Q1 2026.
- Quarterly Operating Leases fell 85.57% year-over-year to $42000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42000.0 (down 85.57% YoY) and the FY2025 annual result came in at $74000.0, down 64.76% from the prior year.
- Operating Leases slipped to $42000.0 in Q1 2026 per IXHL's latest filing, from $53000.0 in the prior quarter.
- Over the last five years, Operating Leases for IXHL reached as high as $470000.0 in Q4 2023 and fell as low as $42000.0 in Q1 2026.
- A 5-year average of $245209.9 and a median of $250500.0 in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases soared 158.93% — and 2026, when it plunged 85.57%.
- Year by year, Operating Leases stood at $181519.0 in 2022, then jumped by 158.93% to $470000.0 in 2023, then slipped by 30.0% to $329000.0 in 2024, then slumped by 83.89% to $53000.0 in 2025, then fell by 20.75% to $42000.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $42000.0, $53000.0, and $64000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 411,000.00 |
| Jun 30, 2024 | 210,000.00 |
| Mar 31, 2024 | 409,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Jun 30, 2023 | 408,000.00 |
| Dec 31, 2022 | 181,519.00 |